MedPath

AMINOSYN II 8.5% INJECTION

AMINOSYN II 8.5% INJECTION

Discontinued
DIN Number

00742627

Drug Class

Human

Market Date

Dec 31, 1987

Company
HC

hospira healthcare ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00742627
AIG Number1750888003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BA01 AMINO ACIDS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:20.00
Health Canada Classification

ACTIVE INGREDIENTS (17)

GLUTAMIC ACIDActive
Strength: 627 MG / 100 ML
Monograph: GLUTAMIC ACID
GLYCINEActive
Strength: 425 MG / 100 ML
Monograph: GLYCINE
HISTIDINEActive
Strength: 255 MG / 100 ML
Monograph: HISTIDINE
L-ALANINEActive
Strength: 844 MG / 100 ML
Monograph: L-ALANINE
L-ARGININEActive
Strength: 865 MG / 100 ML
Monograph: L-ARGININE
L-ASPARTIC ACIDActive
Strength: 595 MG / 100 ML
Monograph: L-ASPARTIC ACID
L-ISOLEUCINEActive
Strength: 561 MG / 100 ML
Monograph: L-ISOLEUCINE
L-LEUCINEActive
Strength: 850 MG / 100 ML
Monograph: L-LEUCINE
L-LYSINE (L-LYSINE ACETATE)Active
Strength: 893 MG / 100 ML
Monograph: L-LYSINE (L-LYSINE ACETATE)
L-PHENYLALANINEActive
Strength: 253 MG / 100 ML
Monograph: L-PHENYLALANINE
L-PROLINEActive
Strength: 614 MG / 100 ML
Monograph: L-PROLINE
L-THREONINEActive
Strength: 340 MG / 100 ML
Monograph: L-THREONINE
L-VALINEActive
Strength: 425 MG / 100 ML
Monograph: L-VALINE
METHIONINEActive
Strength: 146 MG / 100 ML
Monograph: METHIONINE
N-ACETYL-L-TYROSINEActive
Strength: 230 MG / 100 ML
Monograph: N-ACETYL-L-TYROSINE
SERINEActive
Strength: 450 MG / 100 ML
Monograph: SERINE
TRYPTOPHANActive
Strength: 170 MG / 100 ML
Monograph: TRYPTOPHAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.